PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.77%
Net income growth above 1.5x META's 10.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Some yoy growth while META is negative at -17.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
22.98%
SBC growth well above META's 16.57%. Michael Burry would flag major dilution risk vs. competitor’s approach.
97.73%
Slight usage while META is negative at -271.20%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-6.58%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-11.49%
Negative yoy inventory while META is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
45.57%
Lower AP growth vs. META's 144.49%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
75.95%
Growth well above META's 93.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-10.53%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
38.42%
Operating cash flow growth above 1.5x META's 6.39%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-59.03%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-92.58%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
0.63%
Some yoy expansion while META is negative at -95.19%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-12.54%
We reduce yoy sales while META is 198.35%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.31%
Both yoy lines negative, with META at -645.56%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-3370.50%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.77%
Repurchase growth above 1.5x META's 20.28%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.